HEADER SIGNALING PROTEIN 03-MAR-12 4ALG TITLE N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH IBET-151 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: N-TERMINAL BROMODOMAIN, RESIDUES 67-200; COMPND 5 SYNONYM: BRD2, O27.1.1, REALLY INTERESTING NEW GENE 3 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SIGNALING PROTEIN, INHIBITOR, HISTONE, EPIGENETIC READER EXPDTA X-RAY DIFFRACTION AUTHOR C.CHUNG,Y.LAMOTTE,F.DONCHE,A.BOUILLOT,O.MIRGUET REVDAT 2 15-MAY-19 4ALG 1 REMARK REVDAT 1 04-JUL-12 4ALG 0 JRNL AUTH J.SEAL,Y.LAMOTTE,F.DONCHE,A.BOUILLOT,O.MIRGUET,F.GELLIBERT, JRNL AUTH 2 E.NICODEME,G.KRYSA,J.KIRILOVSKY,S.BEINKE,S.MCCLEARY,I.RIOJA, JRNL AUTH 3 P.BAMBOROUGH,C.CHUNG,L.GORDON,T.LEWIS,A.L.WALKER,L.CUTLER, JRNL AUTH 4 D.LUGO,D.M.WILSON,J.WITHERINGTON,K.LEE,R.K.PRINJHA JRNL TITL IDENTIFICATION OF A NOVEL SERIES OF BET FAMILY BROMODOMAIN JRNL TITL 2 INHIBITORS: BINDING MODE AND PROFILE OF I-BET151 JRNL TITL 3 (GSK1210151A). JRNL REF BIOORG.MED.CHEM.LETT. V. 22 2968 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22437115 JRNL DOI 10.1016/J.BMCL.2012.02.041 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.41 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 NUMBER OF REFLECTIONS : 17180 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 914 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 883 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 66.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 40 REMARK 3 BIN FREE R VALUE : 0.3130 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 980 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 127 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.25000 REMARK 3 B22 (A**2) : 0.67000 REMARK 3 B33 (A**2) : 1.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.78000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.089 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.088 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.071 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.956 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1069 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 724 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1451 ; 0.984 ; 1.942 REMARK 3 BOND ANGLES OTHERS (DEGREES): 1767 ; 0.797 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 121 ; 4.565 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 50 ;32.718 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 190 ;11.797 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;18.214 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 149 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1157 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 211 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 26 A 143 REMARK 3 ORIGIN FOR THE GROUP (A): 24.6715 0.6716 14.8435 REMARK 3 T TENSOR REMARK 3 T11: 0.0650 T22: 0.0563 REMARK 3 T33: 0.0434 T12: -0.0134 REMARK 3 T13: -0.0148 T23: -0.0096 REMARK 3 L TENSOR REMARK 3 L11: 2.6160 L22: 0.3223 REMARK 3 L33: 0.5838 L12: 0.1190 REMARK 3 L13: -1.0423 L23: -0.0784 REMARK 3 S TENSOR REMARK 3 S11: 0.0654 S12: 0.1620 S13: 0.0076 REMARK 3 S21: -0.0261 S22: 0.0054 S23: 0.0525 REMARK 3 S31: -0.0602 S32: -0.0131 S33: -0.0708 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4ALG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1290051542. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-SEP-96 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18099 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 44.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.38000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 150MM NH4SO4, 25%MME, 100MM NAAC PH REMARK 280 4.7, 20C, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.02500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.15150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.02500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.15150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 62.98858 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 44.43079 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 SER A 10 REMARK 465 SER A 11 REMARK 465 GLY A 12 REMARK 465 LEU A 13 REMARK 465 VAL A 14 REMARK 465 PRO A 15 REMARK 465 ARG A 16 REMARK 465 GLY A 17 REMARK 465 SER A 18 REMARK 465 HIS A 19 REMARK 465 MET A 20 REMARK 465 SER A 21 REMARK 465 ASN A 22 REMARK 465 PRO A 23 REMARK 465 LYS A 24 REMARK 465 LYS A 25 REMARK 465 THR A 144 REMARK 465 ILE A 145 REMARK 465 PRO A 146 REMARK 465 LYS A 147 REMARK 465 ASN A 148 REMARK 465 SER A 149 REMARK 465 HIS A 150 REMARK 465 LYS A 151 REMARK 465 LYS A 152 REMARK 465 GLY A 153 REMARK 465 ALA A 154 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 143 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 142 -77.05 -93.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2059 DISTANCE = 6.67 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 7-(3,5-DIMETHYL-1, REMARK 600 2-OXAZOL-4-YL)-8-METHOXY-1-[(1R)-1-(PYRIDIN-2-YL)ETHYL]-1H, REMARK 600 2H,3H-IMIDAZO[4,5-C]QUINOLIN-2-ONE (LIG): REFERRED TO REMARK 600 IBET-151 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 1144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1GH A 1146 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1X0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE N-TERMINAL BROMODOMAIN OFHUMAN REMARK 900 BRD2 REMARK 900 RELATED ID: 2YDW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GW841819X REMARK 900 RELATED ID: 2YEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD2 WITH THE REMARK 900 INHIBITOR GSK525762 (IBET) REMARK 900 RELATED ID: 4A9E RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9F RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1- METHYLPYRROLIDIN-2-ONE REMARK 900 RELATED ID: 4A9H RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 1-(2- METHYL-1,2,3,4- REMARK 900 TETRAHYDROQUINOLIN-1-YL)ETHAN-1-ONE REMARK 900 RELATED ID: 4A9I RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3-METHYL-1 ,2,3,4- REMARK 900 TETRAHYDROQUINAZOLIN-2-ONE REMARK 900 RELATED ID: 4A9J RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(4- HYDROXYPHENYL) REMARK 900 ACETAMIDE REMARK 900 RELATED ID: 4A9M RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPENTYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9N RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N- CYCLOPROPYL-5-(3,5- REMARK 900 DIMETHYL-1,2-OXAZOL-4-YL)-2- METHYLBENZENE-1-SULFONAMIDE REMARK 900 RELATED ID: 4A9O RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 5 ETHYL-3 -METHYL-4- REMARK 900 PHENYL-1,2-OXAZOLE REMARK 900 RELATED ID: 4AKN RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH TBUTYL- PHENYL-AMINO- REMARK 900 DIMETHYL-OXAZOLYL-QUINOLINE-CARBOXYLIC ACID REMARK 900 RELATED ID: 4ALH RELATED DB: PDB REMARK 900 N-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH 3,5 DIMETHYL-4-PHENYL-1,2- REMARK 900 OXAZOLE REMARK 999 REMARK 999 SEQUENCE REMARK 999 CRYSTALLISATION PROTEIN USED CONTAINS N-TERMINAL HIS6 TAG. DBREF 4ALG A 21 154 UNP P25440 BRD2_HUMAN 67 200 SEQADV 4ALG GLY A 1 UNP P25440 EXPRESSION TAG SEQADV 4ALG SER A 2 UNP P25440 EXPRESSION TAG SEQADV 4ALG SER A 3 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 4 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 5 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 6 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 7 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 8 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 9 UNP P25440 EXPRESSION TAG SEQADV 4ALG SER A 10 UNP P25440 EXPRESSION TAG SEQADV 4ALG SER A 11 UNP P25440 EXPRESSION TAG SEQADV 4ALG GLY A 12 UNP P25440 EXPRESSION TAG SEQADV 4ALG LEU A 13 UNP P25440 EXPRESSION TAG SEQADV 4ALG VAL A 14 UNP P25440 EXPRESSION TAG SEQADV 4ALG PRO A 15 UNP P25440 EXPRESSION TAG SEQADV 4ALG ARG A 16 UNP P25440 EXPRESSION TAG SEQADV 4ALG GLY A 17 UNP P25440 EXPRESSION TAG SEQADV 4ALG SER A 18 UNP P25440 EXPRESSION TAG SEQADV 4ALG HIS A 19 UNP P25440 EXPRESSION TAG SEQADV 4ALG MET A 20 UNP P25440 EXPRESSION TAG SEQRES 1 A 154 GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY LEU SEQRES 2 A 154 VAL PRO ARG GLY SER HIS MET SER ASN PRO LYS LYS PRO SEQRES 3 A 154 GLY ARG VAL THR ASN GLN LEU GLN TYR LEU HIS LYS VAL SEQRES 4 A 154 VAL MET LYS ALA LEU TRP LYS HIS GLN PHE ALA TRP PRO SEQRES 5 A 154 PHE ARG GLN PRO VAL ASP ALA VAL LYS LEU GLY LEU PRO SEQRES 6 A 154 ASP TYR HIS LYS ILE ILE LYS GLN PRO MET ASP MET GLY SEQRES 7 A 154 THR ILE LYS ARG ARG LEU GLU ASN ASN TYR TYR TRP ALA SEQRES 8 A 154 ALA SER GLU CYS MET GLN ASP PHE ASN THR MET PHE THR SEQRES 9 A 154 ASN CYS TYR ILE TYR ASN LYS PRO THR ASP ASP ILE VAL SEQRES 10 A 154 LEU MET ALA GLN THR LEU GLU LYS ILE PHE LEU GLN LYS SEQRES 11 A 154 VAL ALA SER MET PRO GLN GLU GLU GLN GLU LEU VAL VAL SEQRES 12 A 154 THR ILE PRO LYS ASN SER HIS LYS LYS GLY ALA HET ACT A1144 4 HET GOL A1145 6 HET 1GH A1146 31 HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETNAM 1GH 7-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-8-METHOXY-1-[(1R)-1- HETNAM 2 1GH (PYRIDIN-2-YL)ETHYL]-1H,2H,3H-IMIDAZO[4,5-C]QUINOLIN- HETNAM 3 1GH 2-ONE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ACT C2 H3 O2 1- FORMUL 3 GOL C3 H8 O3 FORMUL 4 1GH C23 H21 N5 O3 FORMUL 5 HOH *127(H2 O) HELIX 1 1 THR A 30 VAL A 39 1 10 HELIX 2 2 VAL A 39 LYS A 46 1 8 HELIX 3 3 ALA A 50 ARG A 54 5 5 HELIX 4 4 ASP A 66 ILE A 71 1 6 HELIX 5 5 ASP A 76 ASN A 86 1 11 HELIX 6 6 ALA A 91 ASN A 110 1 20 HELIX 7 7 ASP A 114 ALA A 132 1 19 SITE 1 AC1 4 ARG A 54 LYS A 69 HOH A2024 HOH A2053 SITE 1 AC2 8 ASP A 58 HIS A 68 ASP A 114 ASP A 115 SITE 2 AC2 8 HOH A2042 HOH A2102 HOH A2125 HOH A2126 SITE 1 AC3 12 TRP A 51 PRO A 52 PHE A 53 LEU A 62 SITE 2 AC3 12 LEU A 64 HIS A 68 LYS A 72 ASN A 110 SITE 3 AC3 12 ILE A 116 HOH A2034 HOH A2055 HOH A2126 CRYST1 82.050 40.303 48.347 90.00 113.22 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012188 0.000000 0.005229 0.00000 SCALE2 0.000000 0.024812 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022507 0.00000